September 18, 2009
The drugs in Trizivir are called nucleoside analog reverse transcriptase inhibitors, or nukes. These drugs block the reverse transcriptase enzyme. This enzyme changes HIV's genetic material (RNA) into the form of DNA. This has to occur before HIV's genetic code gets inserted into an infected cell's own genetic codes.
There are no absolute rules about when to start antiretroviral therapy (ART). You and your health care provider should consider your CD4 cell count, your viral load, any symptoms you are having, and your attitude about taking ART. Fact Sheet 404 has more information about guidelines for the use of ART.
If you take Trizivir with other ARVs, you can reduce your viral load to extremely low levels, and increase your CD4 cell counts. This should mean staying healthier longer.
Trizivir provides three drugs in one pill. It can be more convenient to use Trizivir than some other combinations of drugs. This could mean fewer missed doses and better control of HIV.
Trizivir can be an effective combination of ARVs in one pill. However, it is less effective than combinations that include a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor. It should only be used by itself in special situations.
Some people with HIV had their hepatitis B get worse after they stopped taking lamivudine, which is part of Trizivir. Get tested for hepatitis B before you start taking Trizivir to treat HIV. If you have hepatitis B and stop taking Trizivir, your health care provider should carefully monitor your liver function for several months.
Sometimes, if your virus develops resistance to one drug, it will also have resistance to other ARVs. This is called "cross-resistance."
Resistance can develop quickly. It is very important to take ARVs according to instructions, on schedule, and not to skip or reduce doses.
Trizivir can be taken with food, or between meals.
The dosage of lamivudine should be reduced for people who weigh less than 50 kilograms (110 pounds). People who weigh less than 110 pounds should normally not take Trizivir.
The most common side effects of Trizivir are the same as with the drugs it contains: zidovudine, lamivudine and abacavir. They include headache, upset stomach, nausea, and fatigue. Fact Sheet 551 has more information on fatigue.
The most serious side effects of zidovudine are anemia and muscle problems. Very few people have these side effects. If they occur, your health care provider will probably have you stop using Trizivir. See Fact Sheet 411 for more information on these side effects and Fact Sheet 552 on anemia.
The most serious side effect of abacavir is a hypersensitivity reaction. The FDA recommends a genetic test before using abacavir. This blood test identifies people at high risk of developing the hypersensitivity reaction. People who have this reaction have to stop taking abacavir and cannot take it again. If they do, they will have a serious and possibly fatal reaction. See Fact Sheet 416 for more information on the abacavir hypersensitivity reaction.
The reaction usually starts within two weeks of starting abacavir. Patients had the following symptoms: fever, rash, headache, feeling bad, no energy, nausea, vomiting, diarrhea, stomach pain, cough, shortness of breath, and sore throat. If you develop any of these symptoms while taking Trizivir, call your health care provider immediately.
Trizivir should not be taken with stavudine (d4T, Zerit) or with emtricitabine (Emtriva, FTC).
Blood levels of lamivudine may be increased by bactrim or septra. See Fact Sheet 535 for more information on these drugs.
Zidovudine's side effects may be worse if you are taking several other drugs.
Methadone may increase blood levels of zidovudine. If you take Trizivir and methadone, watch for zidovudine side effects.